• Company marked host of major milestones and accomplishments in 2021
• Approvals, licenses, expansions and growth all essential pieces of Cybin success
• CYBN’s innovative operational and R&D pipeline platforms expected to support four first-in-human clinical studies in 2022

As the new year begins, Cybin (NEO: CYBN) (NYSE American: CYBN) couldn’t be in a better position. The biopharmaceutical company’s commitment to establishing a stronghold in the psychedelics space paid off big last year, with the company marking a host of major milestones and accomplishments and looking toward more of the same for 2022. “2021 was an exciting year for Cybin,” said Cybin CEO Doug Drysdale. “We expanded our organization from five to more than 55 employees across four countries and have established an operating ecosystem of nearly 50 partners and vendors that have supported more than 90 preclinical studies and numerous patent and investigational new drug filings over the past 12 months.” And that’s just the beginning for the emerging leader in the psychedelics industry. The company points to several key highlights this past year as proof positive it is on the right road to psychedelic success. Ranking at the top of 2021 milestones were the notice of allowance awarded from the U.S. Patent and Trademark Office for Cybin’s CYB004 (deuterated psychedelic tryptamine) for the treatment of anxiety disorders and FDA approvals for the company’s cofunded investigator-initiated phase 2 clinical trial. Using the EMBARK psychedelic facilitator training program, the trial is designed to evaluate psychedelic-assisted psychotherapy to treat frontline clinicians experiencing COVID-related distress. In addition, company leaders confirmed a scientific advice meeting with the UK’s Medical and Healthcare Products Regulatory Agency regarding CYBN’s lead candidate CYB003 for the treatment of major depressive disorder and alcohol use disorder. Cybin also announced positive CYB003 data showing significant advantages compared to oral psilocybin for the treatment of mental health disorders, including a 50% reduction in variability, a 50% reduction in dose, a 50% shorter time to onset and nearly double brain penetration. Other 2021 highlights for Cybin included receiving a grant for a psychedelic treatment clinic at Lenox Hill Hospital, part of the largest healthcare system in New York State, to benefit underserved communities; being granted a schedule I manufacturing license from the U.S. Drug Enforcement Agency for its Boston-area research lab, which will allow the company to expand its internal R&D capabilities; receiving approval from the FDA for its investigational new drug application to proceed with a company-sponsored feasibility study using the Kernel Flow quantitative neuroimaging technology to measure ketamine’s psychedelic effect on cerebral cortex hemodynamics; and the completion of 74 in-vitro and in-vivo evaluations of the company’s expanding portfolio of psychedelic compounds being designed for potential therapeutic applications for several mental health conditions. There were many more 2021 highlights for Cybin, which expanded operations into Europe and was the first psychedelic company to list on the NYSE American market. “Driven by promising and differentiating preclinical data, our innovative operational and R&D pipeline platforms expect to support four first-in-human clinical studies in 2022, which we hope will progress our proprietary psychedelic development candidates CYB003 and CYB004 closer toward potential approval for treating depression and addiction disorders,” Drysdale stated. “We believe 2022 will be a truly transformative year for Cybin.” Cybin is a leading ethical biopharmaceutical company on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on progressing psychedelics to therapeutics by engineering proprietary drug-discovery platforms, innovative drug-delivery systems, novel formulation approaches and treatment regimens for mental health disorders. For more information, visit the company’s website at www.Cybin.com. NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

• Mr. Josh Bartch, the CEO, Chairman, and Co-Founder of Mydecine, attributed the company’s success to its phased approach to product research and development
• He noted significant strides in smoking cessation and PTSD research over the 2021 calendar year, which will be integral to operations in the new year
• Mr. Bartch was also proud of the current efficacy data around psilocybin to treat nicotine dependance which is significantly better than what is available in the market
• Going into 2022, Mydecine will embark on more clinical studies on smoking cessation and PTSD, focus more on novel compound production and growing its Mindleap digital health platform

Josh Bartch, the Co-Founder, Chairman, and Chief Executive Officer (“CEO”) of Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: ONFA), recently appeared on The Bell2BellPodcast, a platform meant to highlight key organizations, leaders and entrepreneurs who are leaving a mark in their respective industries. Mr. Bartch briefly shared his background, leading up to co-founding Mydecine, along with the goals for the company for the new year. Of note was Mydecine’s phased approach, which Bartch noted is integral to the company’s operations, along with its future. “Mydecine Innovations Group…is really focused on first- and second-generation novel therapeutics derived from different psychedelic molecules. We’re using those as a blueprint or starting point and then making several improvements for what we call second-generation psychedelic molecules for the treatment of a number of indications,” Bartch noted (https://ibn.fm/kLsnW). So far, Mydecine addresses two lead indications- smoking cessation and PTSD. In 2021, the company partnered with Johns Hopkins University (“JHU”) for further research on smoking cessation and has so far made some significant strides in PTSD treatment. In addition, its phased approach, which entails understanding the imperfections of initial formulations and then modifying them to make them more effective, has already set the company apart from its peers. As a result, the first generation of products is already proving significantly better than what is currently available in the market. “For smoking cessation, for instance, you’re looking at no good solutions currently available,” noted Mr. Bartch. “You have Chantix, which was recently recalled for a cancer-causing carcinogen…Even before, when it was still available on the shelf, this is a blockbuster drug doing $1.2 billion per year with efficacy data in the single digits at 12 months,” he added. With what Mydecine is offering, Bartch noted, early-stage trials have proven to be way better than what was available in the market. Efficacy data has shown upwards of 80% in six months and 67% at 12 months, all attributed to its phased approach. “Through our phased approach, we take that first generation, look at imperfections and make improvements- things in the nature of half-life, controllability delivery time, onset time, anxiety associated with different molecules, etc.,” Bartch reckoned. Going into 2022, Mr. Bartch was keen to note that Mydecine will start two clinical trials- a smoking cessation study and a PTSD Phase 2a study. He also noted the company’s commitment to focusing more on novel compound production and getting them to clinics around the country, which will also be accompanied by publishing pre-clinical results following the studies carried out so far. 2022 will also be the year when Mydecine commercializes its Mindleap digital health platform, as it focuses on growing the number of its users and further improving its offering. To listen to the whole podcast, please visit https://ibn.fm/JQwe2 For more information, visit the company’s website at www.Mydecine.com. NOTE TO INVESTORS: The latest news and updates relating to MYCOF are available in the company’s newsroom at https://ibn.fm/MYCOF

• Mineral property exploration company StraightUp Resources enters 2022 with a new CEO, the tailwind from a new OTCQB Market listing, DTC Eligibility, and encouraging reports on its properties and neighboring properties owned by other companies
• As Americans shift their focus from COVID policies to inflationary pressures and other economic matters, many investors are mulling the appeal of precious metals as a safe haven
• StraightUp holds a mine in the historically productive Bullfrog mining district in Southern Nevada
• The company also holds options for five potentially productive greenbelt sites in Ontario, which the company is assessing

As Americans weary of COVID-19 pandemic restrictions and worry more about the economy and inflations’ effects on their personal finances (https://ibn.fm/zvg2o), many investors are considering a move toward precious metals as a safe haven (https://ibn.fm/PpcPM). Despite recent negative perceptions about gold values, “The December-January period is historically very strong for bullion, which has gained in 8 out of the last 10 Januaries,” a senior investment analyst at brokerage XM recently stated (https://ibn.fm/agG3q). StraightUp Resources (CSE: ST) (OTCQB: STUPF), a company dedicated to acquiring and exploring precious metals resources, is optimistic about the potential of the precious metals market in light of the uncertainty in economic forces at play in the world today. The Canadian company is focusing most of its attention on five projects it has optioned in Ontario’s greenbelt region. The Ferdinand, RLX North and RLX South, Belanger and Bear Head Gold projects sit astride 21,087 hectares (52,107 acres) of potential productivity in a zone already known for gold output topping 30 million ounces. Airborne magnetic surveys (“MAG”) have been completed on three of StraightUp’s properties, and some ground exploration has begun. The company is also enthused about a United States mine property acquired last year in the historically gold-productive Bullfrog region around Beatty, Nev. — particularly in light of news that South African gold major AngloGold Ashanti has upped its investment in the premier mining jurisdiction by buying out Corvus Gold’s shares in order to acquire other Bullfrog region properties (https://ibn.fm/lMWus). StraightUp Resources is similarly encouraged by the potential for stockholder optimism after Kinross Gold Corp. announced last month a definitive agreement with Great Bear Resources Ltd. to buy the company and its holdings, including Red Lake District property neighboring StraightUp’s Ferdinand Gold Project in Ontario (https://ibn.fm/4g505). The company’s international aspirations also led it to contemplate the potential acquisition a silver mine and processing plant in Peru through a right of exclusivity agreement (“ROE”) for all outstanding shares in Premier Silver Corp. that the company announced in October. The ROE had an expiration date in late December if it was not fulfilled, however, and StraightUp ended the year without completing any new acquisitions or business relationships that had not been previously announced, according to a recent monthly progress report (erroneously dated 2021) (https://ibn.fm/mxDyP). In order to build on the company’s potential going into 2022, experienced entrepreneur and economic geologist Rod Husband was named the company’s new CEO in December while former CEO Mark Brezer tightened his focus on his duties as president and director (https://ibn.fm/k6qwp). “We are excited to have Mr. Husband’s calibre of leadership and operational experience on board, especially during this phase of the Company’s growth and expansion into international markets. This appointment strengthens management and brings a new layer of expertise to the team,” Brezer stated in the announcement. The company upgraded to the OTCQB Venture Market in the United States to improve its access to investors, and on Jan. 10 announced a non-brokered private placement to raise additional funding (https://ibn.fm/k74QQ). For more information, visit the company’s website at www.StraightUpResources.com. NOTE TO INVESTORS: The latest news and updates relating to STUPF are available in the company’s newsroom at https://ibn.fm/STUPF

• In August, GreenBox celebrated a monumental milestone when it processed over $1 billion in transaction volume for all of 2021
• GreenBox’s year-to-date processing volume grew to $1.4 billion as of September 30, 2021
• The company reported $8 million in revenue and $5.6 million in gross profit in Q3 2021
• GreenBox appointed Paul Levine as CEO and Co-Founder of Coyni stablecoin spinoff company, Robert Houghton as CTO, and Jacqueline Reynolds as CMO
• The company’s management hosted a year-end update call on December 9

Approximately eight months after GreenBox POS (NASDAQ: GBOX) released its Generation 3 (“Gen3”) technology, which expanded and expedited the process of onboarding, monitoring, and controlling merchant portfolios in its proprietary blockchain-based platform, the company crossed a significant milestone – the processing of more than $1 billion in transaction volume in 2021. The milestone represented about five times the total processing volume recorded in 2020 (https://ibn.fm/IwNLS). Attributable to the Gen3 technology, expansion of its ISO and agent network, and the acquisitions of ChargeSavvy and Northeast Merchant Services, the monumental milestone demonstrated GreenBox’s successful development and deployment of its one-of-a-kind blockchain ledger-based payment processing technology. These factors would again play a significant role in growing the transaction volume figures even further as detailed in a November 11 news release detailing the financial results for the three months ended September 30, 2021 (“Q3 2021”) (https://ibn.fm/GzOeP). GreenBox noted it had processed a quarterly record of $540 million, which contributed to a year-to-date volume of $1.4 billion as of September 30, 2021. Notably, this Q3 2021 transaction volume had grown roughly 1,400% compared to a similar period a year earlier. Other key highlights included a 163% year-over-year (“YoY”) increase in quarterly net revenue from $3.0 million in Q3 2020 to $8.0 million in Q3 2021. Sequentially, the net revenues increased by 26% quarter over quarter (“QoQ”) from $6.4 million recorded in Q2 2021. At the same time, gross profit in Q3 2021 stood at $5.6 million (69.5% of total revenue), compared to $1.2 million (39.6% of total revenue) in Q3 2020 and $5.1 million (79.3% of total revenue) in Q2 2021. Additionally, the company fortified its balance sheet upon securing a $100 million convertible note financing. The fund will go toward supporting its acquisition strategy, adding money to its Coyni stablecoin revolver to grow it up to $25 million, and additional technology development. GreenBox also engaged in revenue sharing and licensing cooperation with Transact Europe enabling it to leverage key licensing assets and recognize processing volume. “Our third quarter of 2021 was instrumental in building the foundation for 2022 and beyond. We continued to successfully execute on our long-term growth strategy of quickly scaling our processing volume while accumulating licensing assets through select acquisitions and partnerships,” commented GreenBox CEO Fredi Nisan. “Despite all GreenBox has accomplished in the last 18 months, we are still just in the early innings of scaling our technology. We remain confident in our long-term strategy and are well positioned to capitalize on the opportunity at hand.” Fredi underlined that the company expects to grow its processing volumes and exceed its initial 2021 guidance of $1.85 billion. Further, GreenBox expects 2021 reported revenue of at least $28 million and adjusted net income of at least $8 million. The third quarter also saw several additions to the company’s management team. GreenBox appointed Paul Levine, a technology innovator and former President of Planet Payment, as CEO and Co-Founder of the Coyni stablecoin spinoff company (“SpinCo”), as it lays the groundwork for the eventual public offering of Coyni. Additionally, the company hired Robert Houghton as the Chief Technology Officer. In this role, Robert will lead GreenBox’s payment technology roadmap as well as ensure efficient integration of acquisitions. On November 16, the company announced the appointment of marketing guru Jacqueline B. Reynolds as its new Chief Marketing Officer (“CMO”). A world-class global marketer, she has launched massive campaigns while working with household names such as Coca-Cola (NYSE: KO), McDonald’s (NYSE: MCD), Verizon (NYSE: VZ), Walmart (NYSE: WMT), L’Oréal, Xbox,  7-Eleven, and other Fortune 500 companies. She has also held senior leadership positions at global brands, top agencies, and media companies, spearheading award-winning programs with international partners. “As CMO, Jacqueline will lead all marketing strategy, including the development of GreenBox’s brand positioning, along with a communications plan to relevantly connect with customers and investors, focused across a variety of platforms,” explains the November 16 news release. Paul Levine and Jacqueline Reynolds joined several other key members of the company’s management, including GreenBox Chairman Ben Errez and Fredi Nisan, in a year-end corporate update call hosted on December 9 (https://ibn.fm/YrkxB). A recording of the call is available via https://ibn.fm/tVbrz (registration required), with a transcript available here https://ibn.fm/kihii. GreenBox is an emerging financial technology enterprise leveraging proprietary blockchain security and token technology to develop customized payment solutions. Guided by the mission to build compliant cutting edge blockchain ledger tokenized payment solutions for the diverse, evolving, and dynamic global market, the company operates along four pillars – card-issuing, payment processing, Coyni stablecoin, and banking-as-a-service. For more information, visit the company’s website at www.GreenBoxPOS.com. NOTE TO INVESTORS: The latest news and updates relating to GBOX are available in the company’s newsroom at https://ibn.fm/GBOX

• SPYR’s Applied MagiX seeks to leverage the large and loyal Apple following to establish its brand in the Apple Ecosystem
• The global smart home market is set to grow at a 15.75% CAGR over the next 5 years, rising to a value of $187 billion per annum by 2025
• SPYR Inc purchased subsidiary, Applied MagiX, to gain access to the smart home market as well as the Apple HomeKit product ecosystem
• As of 2021, Applied MagiX had launched 5 Apple-compatible products with plans to launch a proprietary line of products in the coming future

The Apple ecosystem is second-to-none. Apple has built a fiercely loyal consumer base through its products and services – ranging from Apple computers, peripherals, and iPhones, to services including, Apple News, Apple Fitness+, Apple Arcade and Apple Music. As an indicator of Apple’s significant and long-standing following, the company recently revealed that its App Store had connected with over 600 million people per week across 175 countries, enabling the App Store to generate over $260 billion in cumulative sales since its launch in 2008. Meanwhile, the 2021 holiday season saw App Store customers spend more than ever before between Christmas Eve and New Year’s Eve, driving double-digit growth relative to 2020 (https://ibn.fm/NAYiS). SPYR (OTCQB: SPYR), dba SPYR Technologies, is a technology company which, through its wholly owned subsidiary Applied MagiX Inc., develops and sells Apple(R)-ecosystem-compatible products, seeking to capitalize on the Apple consumer base through product offerings including devices and accessories specifically built on Apple’s HomeKit framework(R). Applied MagiX is a registered Apple developer and reseller. The global smart home market has made its mark as one of the fastest growth segments within the consumer market today, with the sector expected to generate revenue upwards of $104 billion in 2021. That figure is set to grow further still, rising to an annual total of $187 billion by 2025, with a 15.75 percent CAGR over the five-year interim (https://ibn.fm/rFHBu). In late 2020 and after witnessing the stunning growth within the sector, Denver-based SPYR Inc. opted to acquire Californian IoT company, Applied MagiX, with the acquisition propelling SPYR into the multi-billion-dollar smart home industry, and perhaps more critically, giving them entry into the Apple HomeKit smart home market (https://ibn.fm/HBGfJ). Having already begun generating sales and revenue through its partnerships with online retail giants Amazon, Walmart and eBay, SPYR’s Applied MagiX revealed plans to release a proprietary range of products designed to complement and work in conjunction with the Apple HomeKit system. Meanwhile and in the interim, the company has centred its offering around a range of white-labelled Apple HomeKit, Apple CarPlay, and Apple Watch products and accessories drawn from several trusted technology partners, thereby enabling Applied Magix to both generate revenues immediately, whilst simultaneously building an active customer base to introduce their own-branded product range to upon the latter’s release. SPYR and Applied MagiX launched their initial product range in April 2021, with a focus on five key consumer products – the MagixDrive Wireless CarPlay adapter; the HomeKit Secure Video Camera with iCloud Storage; the Multipurpose Sensor with Alarm; the Environment and Motion Sensor; and the Window and Door Contact Sensor. Apple has increasingly sought to combine its product offering as part of their holistic offering which includes iCloud+, thus introducing its home services and hardware to its millions of customers around the globe. With Apple set to become a dominant player within the global smart home sector, SPYR Inc and Applied MagiX look well placed to capitalize on the sector’s spectacular growth rate going forward. For more information, visit the company’s website at www.Spyr.com. NOTE TO INVESTORS: The latest news and updates relating to SPYR are available in the company’s newsroom at https://ibn.fm/SPYR

To give you the most comprehensive conference experience, Talent Acquisition Week 2022 pulls together sourcing, recruiting, and employer branding methods. Start the year off right with the most up-to-date solutions and trends to help you boost your talent acquisition strategy and position your company as a sought-after player in today’s employment market. Key Details

• Social Recruiting Strategies Conference #SRSC
• Employer Branding Strategies Conference #EBrandCon
• Talent Sourcing Strategies Summit

The forthcoming Talent Acquisition Week Conference will be held in a totally digital format on January 24-28, 2022, by the Global Strategic Management Institute, a cutting-edge conference production firm focused on fostering disruptive innovation. Talent Acquisition Week combines sourcing, recruiting, and employer branding tactics into a single event, allowing guests to participate in virtual networking rooms, ask questions, watch live lectures, and network one-on-one with colleagues from across the world. Why Should You Attend? The next Talent Acquisition Week aims to help the Talent Acquisition (“TA”) community apply new tactics, tools, and technology in order to advance their corporate playbooks. Over 50 presentations will be offered by renowned TA practitioners, and attendees will discover the most up-to-date and relevant recruiting, branding, and sourcing techniques while also hearing how businesses have overcome obstacles that TA processes confront on a regular basis. In addition to the live presentations, the Talent Acquisition Week will provide attendees with the opportunity to network with their human resources peers from across the country, allowing conference delegates to share their experiences and learn about new recruitment strategies with peers from across the country and around the world in a single seamless virtual forum. Andrew Gadomski, Managing Director of Aspen Analytics, will give the opening comments at this year’s event. Over the duration of the conference, there will be a series of live 30-minute presentations on the agenda. Stryker will present “How Intelligence Can Support Talent Acquisition and Your Brand,”, Waterford.Org will present “Using Data to Make Hiring Decisions”, Fountain will present “Leveraging Digital Transformation to Drive Your Talent Acquisition Strategy,” and Shaker Recruitment Marketing will present “Two Words That Will Make Your Employer Brand Diverse & Inclusive.” For more information, please visit https://ibn.fm/NPUrO.

The demand for detailed and accessible scientific knowledge has never been greater, as both consumers and HCPs struggle to adjust to life during COVID while aiming for a brighter future. Your medical affairs team must upskill and stay relevant now more than ever as consumers receive information through new media. DGE’s 5th Digital Strategy & Innovation for Medical Affairs Summit will take place February 7-9th 2022 and is the industry’s largest and most significant event for converting your medical affairs department into one that implements progressive policies and prioritizes patient care. In the digital age, this training will help you identify best practices for providing value to both internal and external stakeholders. Key Points

• Boost your competitiveness by improving your data literacy.
• Using innovative digital tactics, provide the greatest possible treatment and outcomes for patients.
• Ensure that your teams are up to date on emerging trends while avoiding unneeded fads.
• A vibrant, engaging community that places a premium on creativity at all levels.
• The most important industry event on the subject – with a proven interactive platform!

The information presented at the Digital Strategy & Innovation for Medical Affairs Summit will assist your company in staying current and transforming its medical affairs department. Learn how to implement progressive policies, promote patient centricity, and figure out how to demonstrate value to internal and external stakeholders in the digital age. The Digital Strategy & Innovation for Medical Affairs Summit is a place where individuals and companies can come together to solve problems and network with one another. Register to take part in an interactive seminar that will help you find best practices for establishing a digital strategy. Reasons To Attend The COVID epidemic has ushered in massive changes to which both patients and HCPs are adjusting. The demand for relevant, timely, and exact scientific data is stronger than ever before. The need of the hour is for medical affairs departments to undergo a thorough makeover by implementing new policies and emphasizing patient-centricity, demonstrating value to both internal and external stakeholders in the digital age. Medical practitioners can join their growing community of interactive participants who can understand the ins and outs of the digital revolution by attending this online conference. Industry executives, health providers, and policymakers will gather throughout the conference to discuss potential for innovation, improved accessibility and efficiency, and the digitization of healthcare that the pandemic has sparked. They will also examine and share their perspectives on the issues faced by medical professionals in adjusting to new technologies, as well as the post-COVID environment. For more information visit https://ibn.fm/xYnCR

• RWB marked 2021 with strategic acquisitions, with the most notable of them being Acreage Holdings Inc. and a 45,000 square foot greenhouse in Apopka, Florida
• These strategic investments would see the company steadily grow its revenue, marking a 93% year-over-year growth by Q3
• The year also marked notable appointments, including Ryan Costello and Colby De Zen, both into the company’s Board of Directors
• RWB is confident that the foundations laid down in 2021 will play a vital role in the company’s growth in 2022, as well as creating shareholder value

Since its inception, Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) has remained focused on being a torchbearer, leading a new frontier in American cannabis. Accordingly, its operations have been defined by adhering to the highest ethical, manufacturing, educational, branding, and employment standards available in the industry. These factors have allowed it to set itself apart from other players in the cannabis space. Over the years, RWB has entered strategic brand acquisitions and partnerships to expand its market presence and position, and become one of the key players in the United States cannabis market. This would be one of the company’s highlights for the 2021 calendar year, kicking off with the acquisition of Acreage Holdings Inc. Later in the year, RWB would also mark other notable purchases, including a 45,000 square foot greenhouse in Apopka, Florida (https://ibn.fm/eYzkX). In December, RWB settled CAD$5.1 million debt and refinanced the CAD$12.8 million principal amount of its vendor take-back note to acquire all the issued and outstanding shares of Acreage Florida, Inc. This would mark the close of RWB’s 2021 list of acquisitions which, its management is confident, will be integral to growing its market share and presence in the new year (https://ibn.fm/Md1xP). Strategic investments for the company in 2021 paid off significantly. In Q1 2021, it posted a 14.5% increase in adjusted sales from the previous quarter (“Q4 2020”) (https://ibn.fm/itQJR). In addition, Q2 would mark a 13% increase in revenue over Q1 2021, with Q3 posting a 93% year-over-year increase in revenue, its biggest jump yet (https://ibn.fm/CeQOc). The company attributed this growth to the additional building blocks laid down over the year, as it works towards being even more profitable as time progresses. “In the third quarter, we made excellent progress in laying additional building blocks in our core operating states of Florida, Michigan, and California to become more vertically integrated where it will be most profitable. This will help drive increased revenue and margins for the company,” noted Brad Rogers, RWB’s Chairman and Chief Executive Officer (“CEO”). 2021 would also mark key appointments at RWB, starting with Ryan Costello’s appointment to the Board of Directors. In addition, the company also brought Colby De Zen, a renowned strategic investor, to its Board of Directors. These appointments would be integral to RWB’s growth and its representation within the United States market. Going into 2022, RWB is confident that the foundations laid down over the 2021 calendar year will play a vital role in the company’s growth and creating shareholder value. It has also been vocal about being asset-light and brand-rich, a strategy driven by supporting its brands most profitably. So far, it has put teams in place to help its plan in the different states it operates, a move that it believes will pay off in this new year. For more information, visit the company’s website at www.RedWhiteBloom.com. NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF

• Eat Well Investment Group Inc. is a brand builder and investor in plant-based consumer products, many of which have already established their popularity and function in North American markets
• The company’s investments in 2021 have led to growing revenues, and company officers forecast continuing to grow to about $100 million in sales by the end of 2022
• Eat Well Investment’s majority-owned Amara toddler organic food line was named Amazon’s top new release last year
• The company’s products enjoy a place on big box retail store shelves such as Walmart, Whole Foods, and Sprouts Farmer’s Market, and in January Eat Well announced they are also available nationwide across Canada in Loblaws Inc. stores

As the worldwide COVID-19 pandemic enters its third year, plant-based foods investment company Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) is celebrating the stability of its holdings’ international sales and its prospects for revenue growth during the coming year. Eat Well Investment Group has built its vertically integrated approach to feeding people delicious, more nutritious food at a lower cost than market standard and with greater accessibility at a global scale since turning its focus from providing venture capital funding for early-stage companies, to acquiring companies outright or acquiring majority stakes in companies. The company’s primary aim is to create “transformational opportunities at scale within the plant-based agribusiness (pulse protein) and emergent foodtech CPG space” thanks to an experienced cadre of personnel, and a consumer product line that boasts “proteins, starches, and fiber (that) are now common ingredients in many everyday CPG products (not just vegan), from crackers, snacks, pastas, breads, plant-based meats, and milks/beverages” (https://ibn.fm/nXIB6). After completing acquisition of plant-based food companies Belle Pulses and Sapientia Technology LLC on July 31, Belle Pulses-related revenues had increased more than 35 percent YOY as of the company’s most recent quarterly financials filing, according to the company’s statement. Sapientia launched its first commercial product — plant-based twisted curls snacks created by the company’s founder and president, who invented the highly successful Twisted Cheetos — in December. Eat Well Group plans to scale its new revenue channel during the coming year with additional product offerings (https://ibn.fm/TTPPH). Eat Well’s efforts to promote nutritional health through quality products under its banner also include its agreement in October to acquire a 51 percent initial investment in Pata Foods Inc., which is doing business as healthy and affordable baby and children’s food company Amara. Amara Organic Foods’ toddler line had grown its revenue five times (533 percent) between January 2021 and January 2022, and had the distinction of being named e-commerce giant Amazon’s top new release (https://ibn.fm/diCuz). Amara also enjoys a strong retail footprint through big-box retailers that include Walmart, Whole Foods and Sprouts Farmer’s Market, and as of January, nationwide across Canada in Loblaws Inc. Eat Well has an option to acquire additional ownership in Amara up to 80 percent. As of Dec. 21, the company’s officers stated they expected company revenues to reach $60 million by the end of 2021 and that they are forecasting about $100 million in revenue for 2022. Food security has become a growing concern worldwide amid concerns about climate change, and efforts to diversify agribusiness offerings and focus on climate-friendly food sources such as plant-based products have increased (https://ibn.fm/bKIoO). For more information, visit the company’s website at www.EatWellGroup.com. NOTE TO INVESTORS: The latest news and updates relating to EWGFF are available in the company’s newsroom at https://ibn.fm/EWGFF

• LQwD is the first publicly traded Lightning Network company
• In November 2021, LQwD launched its proprietary SaaS lqwd.tech, a Lightning Network software platform to lower transaction fees, more efficient liquidity, and seamless use of the global payments’ infrastructure
• The platform also helps complete transactions with lower wait times
• Since January 21, 2021, the Lightning Network has seen over 100% growth in multiple areas of development

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a Bitcoin Lightning Network company focusing on the development of institutional-grade payment infrastructure and solutions, has provided a corporate recap covering major highlights since the acquisition of LQwD took place in June 2021 and the creation of the first publicly traded Lightning Network company (https://ibn.fm/QdSVR). “I wanted to take a moment to recap what has been an active six months for LQwD since listing in June,” LQwD CEO Shone Anstey stated. “The remarkable growth of the Lightning Network has validated LQwD’s reason to be hyper-focused on Lightning, and I look forward to continuing to expand our business on this rapidly growing global payment network.” The Lightning Network is a layer two payment technology and solution for the scaling of Bitcoin for microtransaction around the world. Additionally, the network provides users the ability to complete transactions at a rate of millions per second, lowers fees, and offers instant settlement times. Since January 2021, the Lightning Network has seen node growth of 105% for node establishment from 770 to over 15,000, increased Bitcoin capacity from 1,125 BTC to almost 3,000 BTC – up 160% to September 30, 2021, and a 92% increase in the number of payment channels, totaling more than 73,000 up from the initial 38,000. Here is a look at the accomplishments that LQwD has seen since June 2021:

• June 9, 2021: completed a non-brokered private placement for proceeds of C$5,000,000 (US$3.99 million);
• October 28, 2021: completed an offering of 23,000,000 units for proceeds of C$8,050,000 (US$6.4 million);
• Cumulatively acquired over C$9,000,000 (US$7.19 million) worth of Bitcoin as an operating asset on the Lightning Network, increasing the company’s holdings to around 150 Bitcoin;
• Launched the company’s proprietary software as a service (SaaS) – the multi-pronged Lightning Network software platform (lqwd.tech) allows B2B markets, investors, and others broader access, more efficient liquidity, and seamless use of the global payments’ infrastructure;
• Entered into two strategic service agreements – one with Netcoins, Inc., a leading Canadian crypto trading platform and subsidiary of BIGG Digital Assets Inc., and the other with Breez Development Ltd., an Israeli-based Lightning Network wallet provider;
• Experts in the industry, Joost Jager and Roy Sheinfeld were named as strategic advisors for the company, and Alexandra Moxin was named VP of Product for the company;
• Participated in the Adopting Bitcoin – A Lightning Summit in El Salvador from November 16-18, which brought together industry leaders and experts to discuss the future of money and payments in the Central America region and abroad.

In September 2021, El Salvador was the first country to adopt Bitcoin as its legal tender. The rise of Bitcoin in El Salvador is primarily due to the lack of access to financial institutions. The country adopted a digital wallet app for residents and consumers at this time as well. A supporter of the change, El Salvadoran President Nayib Bukele explained that converting the legal tender will also help the population access the billion dollars in remittances that those living outside of their homeland send back each year. As Bitcoin continues to grow in in value and popularity, more people, institutions and companies are looking for dedicated services to help them make purchases and transactions using the cryptocurrency. LQwD expects this trend to continue and that the Lightning Network will be a force for change worldwide and become the global monetary exchange of the future. For more information, visit the company’s website at www.LQwDFinTech.com. NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF